Latest news
25 items- NEWSCash Flow Chronicles: Analyst Dissects Canadian Cannabis Balance Sheets, Market Trends Vs. The USBenzinga recently reviewed the balance sheet and cash flow trends of Canadian LPs (licensed producers). Zuanic & Associates presents crucial factual key findings: Year-to-date (YTD) the Canadian cannabis market has shown steady market growth, reported at +12%, with second-quarter (Q2) of 2023 showing a year-on-year (YoY) growth of +10%. The growth rate is good in the context of Canada's existing legal provinces, but it underperforms the U.S. market, which experienced a YoY growth rate of 9% during the same period. Canada's per capita metrics fall short of those in the U.S. Recreational consumption in Canada is around US$100 per person — much lower than even the less matured U.S. state
- NEWSEXCLUSIVE: Key Insights And 4 Predictions On Cannabis Sector Equity Research For 2024In an exclusive preview from Zuanic & Associates' recent cannabis equity research report, Benzinga reveals four key predictions for the next 18 months. The SAFE Banking bill is expected to pass in the fall of 2024. Key Senate players will aim for a "midpoint" compromise on add-ons and Section 10. Senate passage is likely to put pressure on the House Speaker, given that half of his caucus is in favor. The Biden Administration is expected to reschedule cannabis before the November 2024 election, possibly as Schedule II or III. That could have significant implications, including the elimination of the Section 280E tax code provision for medical cannabis. It would also require a regulatory f
- SECSEC Form 15-12G filed by HEXO Corp.15-12G - HEXO Corp. (0001690947) (Filer)
- NEWS'North Carolina Senate Approves Medical Marijuana Regulatory Appointment As House Leader Says 'Heavy-Handed' Tactics Not Helping Legalization's Fate' - Marijuana Momenthttps://www.marijuanamoment.net/north-carolina-senate-approves-medical-marijuana-regulatory-appointment-as-house-leader-says-heavy-handed-tactics-not-helping-legalizations-fate/ A Republican North Carolina senator is making it clear that he intends to see his medical marijuana legalization bill pass this session despite some obstinance among GOP leadership in the House—and he’s even gone so far as to include medical cannabis regulatory appointments for the yet-to-be-enacted program in a new measure that passed the Senate last week. But Sen. Bill Rabon’s (R) recent acts of defiance—including attaching an amendment to an unrelated House bill that makes its effective date contingent on his me
- NEWS'Major Marijuana Industry Players Launch Super Pac To Advance Cannabis Reform As 2024 Election Heats Up' - Marijuana Momenthttps://www.marijuanamoment.net/major-marijuana-industry-players-launch-super-pac-to-advance-cannabis-reform-as-2024-election-heats-up/ A coalition of marijuana businesses and advocacy groups has launched a new super PAC that will work to “raise the profile of cannabis as a national issue in the 2024 election and beyond.” And part of the strategy will involve finding industry partners to ask their customers to make “round-up” donations at the point of sale when shopping at dispensaries. The U.S. Cannabis Council (USCC) announced on Wednesday that it and its member businesses have formed the “Legalize America” super PAC, which unlike traditional political action committees can accept contri
- NEWS'Schumer Touts Marijuana Banking Bill As Bipartisan Priority, And Republican Sponsor Is Optimistic As Long As Measure Isn't Expanded' -Marijuana Moment Reporthttps://www.marijuanamoment.net/schumer-touts-marijuana-banking-bill-as-bipartisan-priority-and-republican-sponsor-is-optimistic-as-long-as-measure-isnt-expanded/
- NEWSTilray's HEXO Acquisition Creates Canada's Top Cannabis Company With 44% Market Share BoostTilray (NASDAQ:TLRY) is making bold moves to secure a profitable future, and its latest acquisition of HEXO Corp. (NASDAQ:HEXO) has solidified its position as Canada's top cannabis company with a 44% market share boost, expanding its market share by 467 basis points. Despite a challenging market, the strategic combination of Tilray and HEXO is expected to drive revenue growth and create significant opportunities for increased margins and earnings, with projected annualized cost savings of over $27 million, in addition to Tilray's existing annualized cash cost savings of $122 million from the Tilray-Aphria transaction. See Also: Tilray CFO Engages Shareholders On Reddit, Addresses Concerns
- SECSEC Form 25-NSE filed by HEXO Corp.25-NSE - HEXO Corp. (0001690947) (Subject)
- SECSEC Form F-10POS filed by HEXO Corp.F-10POS - HEXO Corp. (0001690947) (Filer)
- SECSEC Form F-10POS filed by HEXO Corp.F-10POS - HEXO Corp. (0001690947) (Filer)
- NEWSHEXO Reports Completion Of Acquisition By Way Of Arrangement With Tilray BrandsHEXO has submitted a voluntary delisting application to the Toronto Stock Exchange and the Nasdaq Stock Market and, as a result of the Arrangement, the Company expects its Common Shares to be delisted from the TSX and the Nasdaq shortly.
- SECSEC Form 6-K filed by HEXO Corp.6-K - HEXO Corp. (0001690947) (Filer)
- PRHEXO Corp. Announces Completion of Acquisition by Way of Arrangement With Tilray Brands, Inc.HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") announced today the closing of the second of two tranches of the non-brokered private placement of Series 1 Preferred Shares (the "Private Placement") previously announced on June 1, 2023 and the subsequent completion of the transactions contemplated by the previously announced statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the "Arrangement") involving the Company and Tilray Brands, Inc. ("Tilray"). "On behalf of HEXO's board and management team, I'd like to extend our deepest thanks to the entire HEXO team for their continued commitment to our business and customers," said Charlie Bow
- NEWS'Schumer Is 'Confident' Marijuana Banking Bill Will Pass This Session, According To Cannabis Entrepreneur Who Spoke To Majority Leader' - Marijuana Momenthttps://www.marijuanamoment.net/schumer-is-confident-marijuana-banking-bill-will-pass-this-session-according-to-cannabis-entrepreneur-who-spoke-to-majority-leader/ Senate Majority Leader Chuck Schumer (D-NY) is “confident” Congress will be able to pass a bipartisan marijuana banking bill this session—and other Democratic senators also echoed that point, according to a cannabis industry entrepreneur who spoke with the lawmakers recently. After speaking at an event focused on higher education last week, Schumer was approached by the CEO of the Colorado-based cannabis company Simply Pure, Wanda James, who became the first Black woman in the country to own a licensed marijuana dispensary in 20
- SECSEC Form 6-K filed by HEXO Corp.6-K - HEXO Corp. (0001690947) (Filer)
- PRHEXO Corp. Announces Receipt of Final Order for Arrangement With Tilray Brands, Inc.HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") announced today that the Ontario Superior Court of Justice (Commercial List) (the "Court") has granted the final order (the "Final Order") in connection with the previously announced statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the "Arrangement"), pursuant to which Tilray Brands, Inc. ("Tilray") will acquire all of the issued and outstanding common shares (the "Common Shares") and non-voting Series 1 Preferred Shares of the Company. Holders of Common Shares of the Company (the "Common Shareholders") will receive 0.4352 of a share of Tilray common stock (the "Tilray Shares") for each w
- NEWSHEXO Announced Receipt of Final Order for Arrangement With Tilray BrandsHEXO Corp. (TSX:HEXO, NASDAQ:HEXO) (“HEXO” or the “Company”) announced today that the Ontario Superior Court of Justice (Commercial List) (the “Court”) has granted the final order (the “Final Order”) in connection with the previously announced statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the “Arrangement”), pursuant to which Tilray Brands, Inc. (“Tilray”) will acquire all of the issued and outstanding common shares (the “Common Shares”) and non-voting Series 1 Preferred Shares of the Company. Holders of Common Shares of the Company (the “Common Shareholders”) will receive 0.4352 of a share of Tilray common stock (the “Tilray Shares”) for each wh
- NEWSCanaccord Genuity Maintains Hold on HEXO, Lowers Price Target to $1Canaccord Genuity analyst Matt Bottomley maintains HEXO (NASDAQ:HEXO) with a Hold and lowers the price target from C$1.5 to C$1.
- NEWSStocks That Hit 52-Week Lows On ThursdayOn Thursday, 64 companies achieved new lows for the year. Key Facts About Today's 52-Week Lows: Royalty Pharma (NASDAQ:RPRX) was the largest company by market cap to set a new 52-week low. Bone Biologics (NASDAQ:BBLG) was the smallest company in terms of market cap to set a new 52-week low. Bone Biologics (NASDAQ:BBLG) shares dropped the most, trading down 54.71% to reach its new 52-week low. Castellum (AMEX:CTM) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low. The following stocks set new 52-week lows on Thursday: Royalty Pharma (NASDAQ:RPRX) stock hit $31.96 on Thursday morning, setting a new 52-week low for a change of down 0.47%. Concentr
- NEWSHEXO Q3 FY23 Revenue Declines 11% QoQ And 53% YoY, Here Are The DetailsHEXO Corp. (NASDAQ:HEXO) (TSX:HEXO) released its financial results for the third quarter of the 2023 fiscal year, revealing total net revenue of CA$21.6 million ($16.2 million), an 11% sequential decline. The decline was, among other factors, driven by lower adult-use sales in Alberta, certain supply issues and delisted products in Quebec, as well as a lower sales focus in the smaller markets of Saskatchewan and Manitoba. Due to increased competition, net sales declined 53% relative to CA$45.6 million in Q3 2022 as a result of the HEXO brand’s decreased market share and performance in the key provincial markets of Ontario, Alberta and Québec. The Zenabis subsidiary (which was deconsolidated
- SECSEC Form 6-K filed by HEXO Corp.6-K - HEXO Corp. (0001690947) (Filer)
- NEWSHEXO Q3 EPS $(0.70), Sales $15.86M Miss $18.92M EstimateHEXO (NYSE:HEXO) reported quarterly losses of $(0.70) per share. This is a 85.29 percent increase over losses of $(4.76) per share from the same period last year. The company reported quarterly sales of $15.86 million which missed the analyst consensus estimate of $18.92 million by 16.17 percent. This is a 65.19 percent decrease over sales of $45.57 million the same period last year.
- NEWSHEXO Q3 Total Net Revenues Decrease 11% Quarter Over Quarter And Decrease 53% Y/Y
- NEWSHEXO: Q3 Earnings InsightsHEXO (NASDAQ:HEXO) reported its Q3 earnings results on Wednesday, June 14, 2023 at 04:30 PM. Here's what investors need to know about the announcement. Earnings HEXO missed estimated earnings by 6900.0%, reporting an EPS of $-0.7 versus an estimate of $-0.01. Revenue was down $29.71 million from the same period last year. Past Earnings Performance Last quarter the company missed on EPS by $0.1 which was followed by a 9.22% drop in the share price the next day. To track all earnings releases for HEXO visit their earnings calendar here. This article was generated by Benzinga's automated content engine and reviewed by an editor.
- NEWSRecap: HEXO Q3 EarningsHEXO (NASDAQ:HEXO) reported its Q3 earnings results on Wednesday, June 14, 2023 at 04:30 PM. Here's what investors need to know about the announcement. Earnings HEXO missed estimated earnings by 6900.0%, reporting an EPS of $-0.7 versus an estimate of $-0.01. Revenue was down $29.71 million from the same period last year. Past Earnings Performance Last quarter the company missed on EPS by $0.1 which was followed by a 9.22% drop in the share price the next day. To track all earnings releases for HEXO visit their earnings calendar here. This article was generated by Benzinga's automated content engine and reviewed by an editor.
HEXO FAQ
6 questionsWhat does HEXO Corp. do?
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and...Where does HEXO stock trade?
HEXO Corp. (HEXO) is listed on NYSE.What sector and industry is HEXO in?
HEXO Corp. operates in the Health Care sector, Pharmaceuticals and Biotechnology industry.What are analysts saying about HEXO?
HEXO Corp. has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Speculative Buy with a $125.00 price target on 2022-03-04. Recent price targets range from $53.00 to $210.00.What companies are similar to HEXO?
Notable peers in the same industry include EPRX (Eupraxia Pharmaceuticals Inc.), ZOM (Zomedica Corp.), RVLP (RVL Pharmaceuticals plc), IMV (IMV Inc.), NVCN (Neovasc Inc.). Compare HEXO side-by-side with any of them on Quantisnow.How can I track HEXO on Quantisnow?
Quantisnow aggregates HEXO Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HEXO to receive live email and push alerts on every new disclosure.